Alon Vitenshtein

908 total citations
16 papers, 709 citations indexed

About

Alon Vitenshtein is a scholar working on Immunology, Epidemiology and Oncology. According to data from OpenAlex, Alon Vitenshtein has authored 16 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 8 papers in Epidemiology and 7 papers in Oncology. Recurrent topics in Alon Vitenshtein's work include Immune Cell Function and Interaction (9 papers), Cytomegalovirus and herpesvirus research (4 papers) and Influenza Virus Research Studies (3 papers). Alon Vitenshtein is often cited by papers focused on Immune Cell Function and Interaction (9 papers), Cytomegalovirus and herpesvirus research (4 papers) and Influenza Virus Research Studies (3 papers). Alon Vitenshtein collaborates with scholars based in Israel, United States and Croatia. Alon Vitenshtein's co-authors include Ofer Mandelboim, Yoav Bauman, Pinchas Tsukerman, Dikla Lankry, Noam Stern‐Ginossar, Nathan Karin, Gizi Wildbaum, Daphna Nachmani, Yiftah Barsheshet and Rachel Yamin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Cancer Research.

In The Last Decade

Alon Vitenshtein

16 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alon Vitenshtein Israel 11 427 287 143 140 96 16 709
Dikla Lankry Israel 8 547 1.3× 187 0.7× 174 1.2× 139 1.0× 168 1.8× 9 813
Hossam A. Abdelsamed United States 13 749 1.8× 625 2.2× 417 2.9× 105 0.8× 61 0.6× 30 1.2k
Nathan A. Krump United States 10 94 0.2× 235 0.8× 127 0.9× 71 0.5× 42 0.4× 11 484
Lisa Rollins United States 18 630 1.5× 575 2.0× 429 3.0× 81 0.6× 78 0.8× 23 1.1k
Daphna Nachmani Israel 10 490 1.1× 390 1.4× 636 4.4× 235 1.7× 536 5.6× 15 1.3k
Max W. Richardson United States 17 516 1.2× 341 1.2× 244 1.7× 159 1.1× 18 0.2× 24 927
Sandra P. Calderon-Copete Switzerland 7 1.3k 3.1× 1.1k 3.9× 305 2.1× 100 0.7× 59 0.6× 9 1.7k
Hyeonjeong Kang South Korea 12 230 0.5× 281 1.0× 130 0.9× 21 0.1× 28 0.3× 21 556
Breanna Caruso United States 9 260 0.6× 199 0.7× 130 0.9× 88 0.6× 57 0.6× 13 573
Dhananjay M. Nawandar United States 11 156 0.4× 424 1.5× 143 1.0× 186 1.3× 70 0.7× 13 595

Countries citing papers authored by Alon Vitenshtein

Since Specialization
Citations

This map shows the geographic impact of Alon Vitenshtein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alon Vitenshtein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alon Vitenshtein more than expected).

Fields of papers citing papers by Alon Vitenshtein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alon Vitenshtein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alon Vitenshtein. The network helps show where Alon Vitenshtein may publish in the future.

Co-authorship network of co-authors of Alon Vitenshtein

This figure shows the co-authorship network connecting the top 25 collaborators of Alon Vitenshtein. A scholar is included among the top collaborators of Alon Vitenshtein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alon Vitenshtein. Alon Vitenshtein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Vitenshtein, Alon, et al.. (2024). Abstract 7539: First-in-class anti-PVR mAb NTX1088 advancing through Phase I: Safe and potent in restoring DNAM1 expression to enhance antitumor immunity. Cancer Research. 84(6_Supplement). 7539–7539. 3 indexed citations
2.
Vitenshtein, Alon, et al.. (2023). Abstract 6657: Phase I trial of first-in-class anti-PVR mAb NTX1088: Restoration of DNAM1 expression as MOA for enhanced antitumor immunity. Cancer Research. 83(7_Supplement). 6657–6657. 1 indexed citations
3.
Atieh, Anas M., Alon Vitenshtein, Guy Cinamon, et al.. (2022). 474 First-in-class anti-PVR mAb NTX1088 restores expression of DNAM1 and augments antitumor immunity. Regular and Young Investigator Award Abstracts. A494–A494. 2 indexed citations
4.
Vitenshtein, Alon, et al.. (2018). Decay of the Stress-Induced Ligand MICA Is Controlled by the Expression of an Alternative 3′ Untranslated Region. The Journal of Immunology. 200(8). 2819–2825. 7 indexed citations
5.
Barsheshet, Yiftah, Gizi Wildbaum, Alon Vitenshtein, et al.. (2017). CCR8+FOXp3+Tregcells as master drivers of immune regulation. Proceedings of the National Academy of Sciences. 114(23). 6086–6091. 170 indexed citations
6.
Vitenshtein, Alon, Yiska Weisblum, Anne Halenius, et al.. (2016). CEACAM1-Mediated Inhibition of Virus Production. Cell Reports. 15(11). 2331–2339. 18 indexed citations
7.
Vitenshtein, Alon, Yoav Charpak‐Amikam, Rachel Yamin, et al.. (2016). NK Cell Recognition of Candida glabrata through Binding of NKp46 and NCR1 to Fungal Ligands Epa1, Epa6, and Epa7. Cell Host & Microbe. 20(4). 527–534. 70 indexed citations
8.
Yamin, Rachel, Yiska Weisblum, Alon Vitenshtein, et al.. (2016). HCMV vCXCL1 Binds Several Chemokine Receptors and Preferentially Attracts Neutrophils over NK Cells by Interacting with CXCR2. Cell Reports. 15(7). 1542–1553. 28 indexed citations
9.
Vitenshtein, Alon, Yaron Drori, Rachel Yamin, et al.. (2016). Suppression of human metapneumovirus (HMPV) infection by the innate sensing gene CEACAM1. Oncotarget. 7(41). 66468–66479. 8 indexed citations
10.
Weisblum, Yiska, Amos Panet, Zichria Zakay‐Rones, et al.. (2015). Human cytomegalovirus induces a distinct innate immune response in the maternal–fetal interface. Virology. 485. 289–296. 23 indexed citations
11.
Yamin, Rachel, Noa Kaynan, Ariella Glasner, et al.. (2013). The Viral KSHV Chemokine vMIP-II Inhibits the Migration of Naive and Activated Human NK Cells by Antagonizing Two Distinct Chemokine Receptors. PLoS Pathogens. 9(8). e1003568–e1003568. 30 indexed citations
12.
Bar‐On, Yotam, Ariella Glasner, Tal Meningher, et al.. (2013). Neuraminidase-Mediated, NKp46-Dependent Immune-Evasion Mechanism of Influenza Viruses. Cell Reports. 3(4). 1044–1050. 49 indexed citations
13.
Tsukerman, Pinchas, Noam Stern‐Ginossar, Chamutal Gur, et al.. (2012). MiR-10b Downregulates the Stress-Induced Cell Surface Molecule MICB, a Critical Ligand for Cancer Cell Recognition by Natural Killer Cells. Cancer Research. 72(21). 5463–5472. 111 indexed citations
14.
Bauman, Yoav, Daphna Nachmani, Alon Vitenshtein, et al.. (2011). An Identical miRNA of the Human JC and BK Polyoma Viruses Targets the Stress-Induced Ligand ULBP3 to Escape Immune Elimination. Cell Host & Microbe. 9(2). 93–102. 146 indexed citations
15.
16.
Lugassy, Jennie, John A. McGrath, Peter Itin, et al.. (2007). KRT14 Haploinsufficiency Results in Increased Susceptibility of Keratinocytes to TNF-α-Induced Apoptosis and Causes Naegeli–Franceschetti–Jadassohn Syndrome. Journal of Investigative Dermatology. 128(6). 1517–1524. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dikla Lankry Breakdown of academic impact, for papers by Hossam A. Abdelsamed Breakdown of academic impact, for papers by Nathan A. Krump Breakdown of academic impact, for papers by Lisa Rollins Breakdown of academic impact, for papers by Daphna Nachmani Breakdown of academic impact, for papers by Max W. Richardson Breakdown of academic impact, for papers by Sandra P. Calderon-Copete Breakdown of academic impact, for papers by Hyeonjeong Kang Breakdown of academic impact, for papers by Breanna Caruso Breakdown of academic impact, for papers by Dhananjay M. Nawandar
Rankless by CCL
2026